Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery
Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the present research study is to investigate for the first time, the safety
and tolerability of infusion doses of AP214 in subjects having heart surgery such as coronary
bypass graft and/or valve repair or replacement surgery. AP214, the investigational drug, is
being developed to potentially prevent post-surgical kidney injury after thoracic aortic
aneurysm repair.